HOME >> BIOLOGY >> NEWS
Four IU professors are 2004 Guggenheim Fellows

BLOOMINGTON, Ind. -- Four Indiana University Bloomington professors have been awarded Guggenheim fellowships, the Guggenheim Foundation announced today (April 8).

Professor of Central Eurasian Studies Christopher Beckwith, Professor Emeritus of Folklore and Ethnomusicology Mary Ellen Brown, Professor of Biology Ellen Ketterson and Distinguished Professor of Biology Loren Rieseberg are among the 2004 fellowship winners.

The 80-year-old Guggenheim fellowships are given "on the basis of distinguished achievement in the past and exceptional promise for future accomplishment," to "men and women devoted to science and liberal studies, great teachers, creators of beauty, and generally to those devoted to pursuits that dignify, ennoble and delight mankind," according to the foundation.

An expert on birds' sexual behavior, Ketterson will use her Guggenheim grant to do something unusual -- bringing contemporary studies of human sexual behavior to bear on similar studies in other animals. Usually, scientists extrapolate in the other direction. Ketterson will examine whether human sex and gender concepts apply in songbirds. Studies she will begin later this year in South Dakota, Nevada, Costa Rica and Mexico will examine how geographic differences in songbird behavior and physiology relate to sex and, possibly, gender. Ketterson is a member of IU's Center for the Integrative Study of Animal Behavior. She is also president of the Kinsey Institute's Board of Governors and has a part-time appointment in IUB's Gender Studies Program.

Rieseberg plans to use his Guggenheim grant to write The Origin and Evolution of Plant Species, a comprehensive, 11-chapter monograph that Rieseberg says will provide a much-needed update to plant biology texts currently available to botanical students and researchers. A leader in plant population genetics and evolution, Rieseberg plans to integrate much of his own scholarly work into the monograph. He also
'"/>

Contact: David Bricker
brickerd@indiana.edu
812-856-9035
Indiana University
8-Apr-2004


Page: 1 2

Related biology news :

1. University of Minnesota professors to speak at symposium on international trade
2. UT Southwestern scientist awarded prestigious American Cancer Society research professorship
3. Nominations sought for professorship by the American Association for Cancer Research
4. Howard Hughes Medical Institutes million dollar professors
5. Washington Universitys Sarah C. R. Elgin is one of 20 million dollar professors
6. K-State professors make discovery in pesticide-resistant bugs
7. Five Rutgers professors named fellows of national science association
8. 20 scientists selected as Aldo Leopold Leadership Fellows
9. UC San Diego places in top tier of institutions awarded 2004 Sloan Research Fellowships
10. Ten Chinese reporters receive AAAS Fellowships
11. Crops society announces Pioneer Fellowship in Plant Sciences

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Four professors are Guggenheim Fellows

(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ... Competitive Profiles - NEC" report to their offering. ... will continue to supply a range of IT security ... company focus on the development of a Big Data ... in the Asia-Pacific region is ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a ... and services, and Morpho, a leading supplier of ... to produce the market,s most advanced biometrically-enabled time ... iSolved NXG time clock is setting a bold, ... labor data for the small and mid-size employer. ...
(Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
(Date:4/16/2015)... (PRWEB) April 16, 2015 Regis Technologies ... American Association for Cancer Research (AACR) annual meeting. Regis ... Convention Center, starting Saturday, April 18, in Philadelphia and ... claim to title of the oldest and largest organization ... fellowships and grants, and partners with survivors to promote ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 ... at Charlotte (UNC Charlotte) spin-out company, announced today ... Cooper, Ph.D., M.D., as Chief Operating Officer (COO). ... of experience in developing clinical diagnostic and biotechnology ... infectious disease. , Cooper’s extensive career transcends the ...
(Date:4/16/2015)... 16, 2015  In recognition of World Hemophilia Day, ... groups to illuminate more than 15 prominent landmarks red throughout ... Boston,s Zakim Bridge and Prudential Tower, ... Mercedes-Benz Superdome and Denver,s ... of April 17, and coincide with hemophilia community events in ...
(Date:4/16/2015)... April 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... U.S. joint venture with G-treeBNT (ReGenTree LLC) has ... clinical trial for the orphan disorder, neurotrophic keratopathy ... dry eye syndrome (DES) in the U.S.  Both ... RGN-259/GBT201, this year.  Each of these eye disorders ...
Breaking Biology Technology:Regis Technologies Joins American Association for Cancer Research Annual Meeting 2OncoTAb Names Dr. David L. Cooper as COO 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 3Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5
Cached News: